Subscribe to RSS
DOI: 10.1055/s-2005-871580
Convenient and Efficient Approach to Di- and Trideoxyribonucleotide N3′→P5′ Phosphoramidates
Publication History
Publication Date:
07 July 2005 (online)
Abstract
Arbuzov reaction of phenyl phosphorodichloridite with an equivalent of allyl alcohol and tert-butyl alcohol produced phenyl allyl H-phosphonate and the subsequent ester-exchange with various nucleosides produced nucleoside allyl H-phosphonates. Antherton-Todd reaction of the nucleoside allyl H-phosphonates with 3′-amino-3′-deoxythymidine yielded dideoxyribonucleotide N3′→P5′ phosphoramidates, and the repetition of this procedure provided trideoxyribonucleotide N3′→P5′ phosphoramidates. The method can be used for the synthesis of oligodeoxyribonucleotide N3′→P5′ phosphoramidates without any protection for all nucleosides.
Key words
nucleotide N3′→P5′ phosphoramidate - H-phosphonate - ester-exchange - Antherton-Todd reaction
- 1
Gryaznov SM.Skórski T.Cucco C.Nieborowska-Skórska M.Chin CY.Lloyd D.Chen J.-K.Koziólkiewicz M.Calabretta B. Nucleic Acids Res. 1996, 24: 1508 - 2
Riordan ML.Martin JC. Nature (London) 1991, 350: 442 - 3
Gryaznov SM.Lloyd DH.Chen J.-K.Schultz RG.DeDionisio LA.Ratmeyer L.Wilson WD. Proc. Natl. Acad. Sci. U.S.A. 1995, 92: 5798 - 4
Giovannangeli C.Diviacco S.Labrousse V.Gryaznov S.Charneau P.Helene C. Proc. Natl. Acad. Sci. U.S.A. 1997, 94: 79 - 5
Gryaznov SM.Letsinger RL. Nucleic Acids Res. 1992, 20: 3403 - 6
Rigl CT.Lloyd DH.Tsou DS.Gryaznov SM.Wilson WD. Biochemistry 1997, 36: 650 - 7
Escude C.Giovannangeli C.Sun JS.Lloyd DH.Chen JK.Gryaznov SM.Garestier T.Helene C. Proc. Natl. Acad. Sci. U.S.A. 1996, 93: 4365 - 8
Mungall WS.Greene GL.Heavner GA.Letsinger RL. J. Org. Chem. 1975, 40: 1659 - 9
Maag H.Schmidt B.Rose SJ. Tetrahedron Lett. 1994, 35: 6449 - 10
Chen J.-K.Schultz RG.Lloyd DH.Gryaznov SM. Nucleic Acids Res. 1995, 23: 2661 - 11
Gryaznov S.Chen J.-K. J. Am. Chem. Soc. 1994, 116: 3143 - 12
Chen J.-K.Schultz RG.Lloyd DH.Gryaznov SM. Nucleic Acids Res. 1995, 23: 2661 - 13
Schultz RG.Gryaznov SM. Nucleic Acids Res. 1996, 24: 2966 - 14
Uznanski B.Grajkowski A.Krzyzanowska B.Kazmierkowska A.Stec WJ.Wieczorek MW.Blaszczyk J. J. Am. Chem. Soc. 1992, 114: 10197 - 15
Baraniak J.Korczyñski D.Stec WJ. J. Org. Chem. 1999, 64: 4533 - 16
Garegg PJ.Lindh I.Regberg T.Stawinski J.Strömberg R.Henrichson C. Tetrahedron Lett. 1986, 27: 4051 - 17
Garegg PJ.Lindh I.Regberg T.Stawinski J.Strömberg R.Henrichson C. Tetrahedron Lett. 1986, 27: 4055 - 18
Froehler BC.Matteucci MD. Tetrahedron Lett. 1986, 27: 469 - 19
Froehler BC.Ng PG.Matteucci MD. Nucleic Acids Res. 1986, 14: 5399 - 20
Stawinski J.Kraszewski A. Acc. Chem. Res. 2002, 35: 952 - 21
Kers I.Stawinski J. Tetrahedron Lett. 1998, 39: 1219 - 22
Kers I.Stawinski J. Tetrahedron 1999, 55: 11579
References
Spectral data for the representative products 6b and 8b.
Compound 6b: 31P NMR (121.5 MHz, DMSO-d
6): δ = 10.37, 10.26 ppm. 1H NMR (300 MHz, DMSO-d
6): δ = 1.76 (s, 3 H, 5-CH3 of 3′-amino-3′-deoxythymidine), 1.78 (s, 3 H, 5-CH3 of 3′-deoxythymidine), 2.11-2.17 (m, 5 H, 2′-H of 3′-amino-3′-deoxythymidine and 3′-deoxythymidine and 4′-H of 3′-amino-3′-deoxythymidine), 3.50-3.65 (m, 2 H, 3′-H of 3′-amino-3′-deoxythymidine and 3′-H of 3′-deoxythymidine), 3.65-3.93 (m, 2 H, 5′-H of 3′-amino-3′-deoxythymidine), 4.01 (m, 1 H, 4′-H of 3′-deoxythymidine), 4.01-4.11 (m, 2 H, 5′-H of 3′-deoxythymidine), 4.21-4.30 (m, 1 H, 3′-NH of 3′-amino-3′-deoxythymidine), 4.39-4.47 (m, 2 H, OCH
2-CH=CH2), 5.17-5.35 (m, 2 H, OCH2-CH=CH
2), 5.88-6.00 (m, 1 H, OCH2-CH=CH2), 6.12 (t, 1 H, 3
J = 6.18 Hz, 1′-H of 3′-amino-3′-deoxythymidine), 6.19 (t, 1 H, 3
J = 6.87 Hz, 1′-H of 3′-deoxythymidine), 7.52 (s, 1 H, 6-H of 3′-amino-3′-deoxythymidine), 7.73 (s, 1 H, 6-H of 3′-deoxythymidine), 11.29 (s, 1 H, 3-H of 3′-amino-3′-deoxythymidine), 11.32 (s, 1 H, 3-H of 3′-deoxythymidine) ppm. 13C NMR (75 MHz, DMSO-d
6): δ = 12.11, 12.26, 60.39, 65.58, 65.97, 66.05, 70.21, 70.30, 83.24, 83.88, 84.69, 85.80, 109.21, 109.83, 117.04, 133.53, 133.62, 135.81, 136.18, 150.35, 150.42, 163.70, 163.76 ppm. ESI-MS: m/z = 586.4 [M + H]+, 608.2 [M + Na]+.
Compound 8b: 31P NMR (121.5 MHz, DMSO-d
6): δ = 10.08, 10.30 ppm. 1H NMR (300 MHz, DMSO-d
6): δ = 1.76 (s, 3 H, 5-CH3 of 3′-amino-3′-deoxythymidine), 1.78 (s, 6 H, 5-CH3 of 3′-deoxythymidine and 3′-amino-3′-deoxythymidine), 1.99-2.35 (m, 6 H, 6 × H-2′), 3.54-3.86 (m, 5 H, H-4′ of 3′-deoxythymidine and 2 × H-5′), 3.87-4.33 (m, 8 H, 2 × H-4′, 4 × H-5′ and 2 × H-3′ of 3′-amino-3′-deoxythymidine), 4.33-4.50 (m, 3 H, 2 OCH
2-CH=CH2 and H-3′ of 3′-deoxythymidine), 5.10-5.38 (m, 4 H, 2 OCH2-CH=CH
2), 5.83-6.02 (m, 2 H, 2 OCH2-CH=CH2), 6.04-6.26 (m, 3 H, H-1′), 7.54 (s, 2 H, H-6 of 3′-deoxythymidine and 3′-amino-3′-deoxythymidine), 7.74 (s, 1 H, H-6 of 3′-amino-3′-deoxythymidine), 11.23-11.36 (m, 3 H, 3 × H of NH-3) ppm. 13C NMR (75 MHz, DMSO-d
6): δ = 12.60, 12.73, 50.82, 51.22, 60.76, 65.61, 65.76, 66.21, 66.51, 66.57, 66.74, 66.80, 70.59, 70.61, 79.75, 83.72, 83.97, 84.40, 85.03, 85.10, 86.35, 86.49, 109.72, 110.25, 110.34, 117.57, 117.74, 133.90, 133.97, 136.30, 136.72, 150.75, 150.84, 164.18 ppm. ESI-MS: m/z = 951.9 [M + Na]+.